While the breadth of digital health products available to the market continues to expand, Hamza Drabu, partner and head of health at DAC Beachcroft,...
Medtech innovators face an increasingly complex regulatory framework following Brexit. Ian Manners, a regulatory partner at UK law firm Ashfords, looks at the challenges...
Germany’s landmark cannabis law marks a significant step forward for the European cannabis landscape, argues Thomas Schatton, CEO of Four 20 Pharma, a Curaleaf...
In September 2023, the European Medicines Agency (EMA) will reinstate Policy 0070 meaning that clinical data submitted for the purposes of regulatory approval will...
An increasing number of clinical studies show promising results for the use of psychedelic therapies in the treatment of various mental health conditions. Research...
To mark mental health awareness week, Investors in Healthcare asked consultant psychiatrist and medico-legal expert Dr Nick Cooling and Zahra Awaiz-Bilal, senior associate in...
Recent developments in AI, including DALL-E 2 and ChatGPT, have reignited widespread excitement about the potential of AI across all aspects of our lives....
New legislation is before the select committee which could significantly change the regulatory landscape for businesses involved in the medical device industry (including manufacturers,...